In humans, some clinical series have shown changes in the plasma concentrations of TGF-β1 and IL-6 during radiotherapy suggesting that these variations could identify patients at risk of radiation pneumonitis [24-26]. This evidence concerns the gene TGFB1 and radiation pneumonitis.